EGFR overexpression + HER-2 overexpression
|
Cholangiocarcinoma
|
EGFR overexpression + HER-2 overexpression
|
Cholangiocarcinoma
|
ASLAN001 Sensitive: D – Preclinical
|
ASLAN001 Sensitive: D – Preclinical
|
EGFR overexpression + HER-2 overexpression
|
Cholangiocarcinoma
|
EGFR overexpression + HER-2 overexpression
|
Cholangiocarcinoma
|
AN2025 + ASLAN001 Sensitive: D – Preclinical
|
AN2025 + ASLAN001 Sensitive: D – Preclinical
|